Product
Pemvidutide
1 clinical trial
1 indication
Indication
Non-Alcoholic SteatohepatitisClinical trial
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in Non-Cirrhotic Subjects With Nonalcoholic Steatohepatitis (NASH)Status: Recruiting, Estimated PCD: 2025-02-28